Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention

BACKGROUND: Diabetic patients with on-treatment high platelet reactivity (HPR) show an increased risk of thrombotic events. Whether measuring glycated haemoglobin (HbA1c) levels and/or glycaemic variability (GV) may help identifying diabetic patients at higher risk deserving tailored antiplatelet an...

Descripción completa

Detalles Bibliográficos
Autores principales: Nusca, Annunziata, Tuccinardi, Dario, Proscia, Claudio, Melfi, Rosetta, Manfrini, Silvia, Nicolucci, Antonio, Ceriello, Antonio, Pozzilli, Paolo, Ussia, Gian Paolo, Grigioni, Francesco, Di Sciascio, Germano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842151/
https://www.ncbi.nlm.nih.gov/pubmed/31706305
http://dx.doi.org/10.1186/s12933-019-0952-8

Ejemplares similares

Ejemplares similares